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TO THE EDITOR
Angermeyer et al. (2013) claim that
‘‘Merkel Cell Polyomavirus–Positive
Merkel Cell Carcinoma Cells Do Not
Require Expression of the Viral Small T
Antigen.’’ This controversial conclusion
is based on their inability to detect
Merkel cell polyomavirus (MCV) small
T (sT) protein expression and to inhibit
cell growth by putative sT knockdown
in MCV-MCC (Merkel cell carcinoma)
cells.
These findings contradict existing evi-
dence showing MCV sT protein expres-
sion in MCV-MCC cancer tissues (Shuda
et al., 2011) and cell lines (see Figure 2,
Houben et al., 2010) (Guastafierro et al.,
2013). To investigate this discrepancy,
we tried replicating the results of
Angermeyer et al., (2013) using the
same antibodies to detect MCV sT
(CM8E6 (Kwun et al., 2009), CM5E1
(Shuda et al., 2011), and 2T2 (Wang
et al., 2012), kindly provided by
C. Buck) on a panel of MCV-MCC cell
lines (Figure 1). MCV sT and large T (LT)
are alternatively spliced viral oncopro-
teins sharing a common N terminus but
having different C-termini, thus CM8E6
and 2T2 detect all isoforms of T-anti-
gens, while CM5E1 detects only sT and
CM2B4 detects only LT and related iso-
forms. Differences in protein expression
levels between MCV LT and sT are likely
dependent on either pre-mRNA or post-
transcriptional protein processing. For
positive and negative controls, we used
UISO cells transiently transfected with
the MCV T-antigen locus (JN038578) or
with corresponding empty vector. UISO,
commonly described as being from
MCC origin (Houben et al., 2007), is
negative for MCV and miRNA ontology
studies show it clusters with cell lines
of breast cancer origin (Renwick et al.,
2013). In contrast to Angermeyer et al.,
the 19 kD MCV sT band is readily
detected in all MCV-MCC cell lines
(open arrows) but not in UISO cells.
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Figure 1. Detection of Merkel cell polyomavirus (MCV) small T (sT) antigen expression by multiple MCV T-antigen antibodies. MCV-positive Merkel cell
carcinoma (MCC) cells (MKL-1, MKL-2, MS-1, and WaGa) and MCV-negative UISO cells transfected with MCV genomic T-antigen gene or empty vector as
positive and negative controls, were immunoblotted with multiple MCV T-antigen antibodies. a-Tubulin was used as a loading control. Both large T (LT, closed
arrows) and small T (sT, open arrows) were detected by CM8E6 and 2T2, sT by CM5E1, and LT by CM2B4. Asterisks indicate non-specific bands. Peptide
sequences used for mAb production and shRNA targeting sites are shown in the bottom diagram of T-antigen transcripts with a DnaJ (green box), an Rb-binding
(black box) as well as large T stabilization (LSD, yellow box (Kwun et al., 2013)) domains.
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RNAs (shRNAs), and directly contra-
dict our findings that sT knockdown
inhibits cell replication in MCV-MCC
(Shuda et al., 2011). Since Angermeyer
et al. were not able to measure sT
protein by immunoblotting, efficacy of
knockdown could not be determined.
To assess cell proliferation, Angermeyer
et al. (2013) used a competition
assay containing mixtures of shRNA-
transduced and nontransduced cells
that compete with each other for
growth. We instead directly measured
cell proliferation using standard Wst-1
assays. To resolve this, we generated
the same two sT-specific shRNAs
cloned in pLKO.1-based lentiviral
vector (named here sT1.RH for Roland
Houben and sT2.RH) used in their study
and compared these two shRNAs to an
shRNA previously described to target sT
alone (designated here as sh sT1.MS for
Masahiro Shuda), an shRNA targeting
both LT and sT (sh panT.MS) and a
scrambled negative control shRNA (sh
ctrl) (Shuda et al., 2011). Both sh
sT1.MS and sh panT.MS inhibit sT
protein expression measured by
quantitative LI-COR immunoblotting
(Figure 2a and b) and cell growth
(Figure 2c) as previously described
(Shuda et al., 2011). One shRNA (sh
sT1.RH) of Angermeyer et al. also
inhibits sT expression and signifi-
cantly inhibits MCV-MCC cell growth.
However, St1.RH also showed reduced
proliferation of UISO cells consistent
with an off-target effect that precludes
its use as a specific targeting agent for
MCV sT. The other shRNA (sh sT2.RH)
has minimal (MKL-2) or no (MKL-1) sT
knockdown activity (Figure 2b). It
nonetheless inhibits MCV-MCC cell
growth. Given the inability to monitor
sT knockdown and off-target effects for
the sT.RH shRNAs used in the knock-
down studies of Angermeyer et al.
(2013), attempts to rescue MCC cell
proli-
feration using combinations of LT and
sT expression during sT knockdown are
not interpretable.
Using the same shRNA constructs
described by Angermeyer et al. (2013),
we show that their conclusion that MCV
sT has no role in MCV is not correct. We
recommend using sh sT1.MS, which is
efficacious in sT knockdown and we
are unaware of any off-target activity.
Mixed cell competition assays to
measure proliferation are fraught with
uncertainty since paracrine effects can
distort proliferation measurements and
more traditional cell counting or
Wst-1 measurements are preferred.
Finally, as co-equal authors that
independently developed T-antigen
shRNA knockdowns for the report
describing T-antigen knockdown in
MCC (Houben et al., 2010), we dis-
agree with these authors’ assertion that
pan-T knockdown induces apoptosis in
MCC. Weak poly ADP-ribose poly-
merase cleavage (Figure 5B, Houben
et al., 2010) can be seen in some cell
lines during knockdown, but it is not
universally present, and Casp3 or Casp9
cleavage is completely absent. As
confirmed by Angermeyer et al. (2013),
MCV sT is the only known transforming
oncoprotein of MCV in rodent cells
while MCV LT alone is not sufficient to
transform rodent fibroblast cells (Shuda
et al., 2011; Angermeyer et al., 2013). In
the SV40 T-antigen model of human cell
transformation, expression of both LT
and sT is required (Hahn et al., 1999).
Taking into consideration the higher
tumorigenic barrier in human cells
as compared to rodent cells and that
the spliced sT isoform is expressed
together with LT in most MCC (Shuda
et al., 2011), it is likely that MCV sT co-
contributes with MCV LT to MCC
carcinogenesis.
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Figure 2. Merkel cell polyomavirus (MCV) small T (sT) antigen knockdown inhibits MCV-positive Merkel
cell carcinoma (MCC) cell proliferation. (a) MCV-positive MCC cell lines, MKL-1 and MKL-2, were
transduced with pLKO.1-based lentiviral shRNAs targeting both LT and sT (panT.MS) or sT alone (sT1.MS,
sT1.RH, and sT2.RH) as described (Houben et al., 2010). Both LT (closed arrows) and sT (open arrows)
proteins are detected by 2T2. (b) Expression of LT and sT was quantitated by LI-COR IR immunoblotting
system using a-Tubulin for normalization. Relative sT expression to sh ctrl is shown. (c) Small hairpin RNA
(shRNA)-transduced MCV-positive (MKL-1 and MKL-2) cells and MCV-negative (UISO) cells were
subjected to Wst-1 cell proliferation assay. Error bars indicate SD.
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TO THE EDITOR
The Merkel cell polyoma virus (MCV),
which is associated with Merkel cell
carcinoma (MCC), codes for two onco-
proteins termed large and small T anti-
gen (LT and sT). Although different MCC
cell lines clearly depend on the expres-
sion of MCV LT (Houben et al., 2012),
our results (complete rescue of growth
inhibition induced by an small hairpin
RNA (shRNA) targeting both of the
differentially spliced T antigens by
reexpression of only an shRNA-insensi-
tive LT) recently published in the Journal
of Investigative Dermatology suggest that
MCV-positive MCC cells do not require
the expression of sT for proliferation
(Angermeyer et al., 2013). Now, Shuda
et al. (2013) respond to this publication
with a letter stating the opposite on the
basis of their observation that one shRNA
targeting MCV sT (sh sT1.MS) induces
reduced sT expression and reduced
proliferation in two MCV-positive MCC
cell lines (MKL-1 and MKL-2), while
having no effect on a control cell line
(UISO; Shuda et al., 2013); two other
evaluated sT shRNA constructs either
lacked significant knockdown capability
or affected the growth of a control cell
line, thus suggesting off-target effects.
Moreover, as LT is essential for MCV-
MCC cells, data from the same group
showing that sT functions to stabilize LT
protein in MCC cells (Kwun et al. (2013),
Supplementary Figure S2B) would further
suggest that sT is also required. Surpri-
singly, however, such a dependency of
LT on sT expression is not supported by
the data now presented by Shuda et al.
(2013) as sT knockdown does not affect
LT expression (Shuda et al. (2013),
Figure 2a). Therefore, the conclusion
that MCV-MCC cells require sT is
based only on the growth-inhibiting
effect of the shRNA sh sT1.MS. No-
tably, cytotoxic or cytostatic off-target
effects frequently affect the interpre-
tation of RNA interference experiments
and vary between cell lines (Fedorov
et al., 2006). Thus, although the authors
demonstrate that the MCV-negative cell
line UISO is not affected by sh sT1.MS,
such effects cannot be completely ruled
out for MKL-1 and MKL-2. Interestingly,
within the data set provided by Shuda
et al. (2013) there is a clear example for
such a cell type–specific off-target effect:
the construct shRNA sT2.RH, which is
described by Shuda et al. (2013) to have
‘‘minimal (MKL-2) or no (MKL-1) sT
knockdown activity’’, completely inhibi-
ted the growth of the two MCV-positive
MCC cell lines, whereas the proliferation
of UISO was not affected at all (Shuda
et al., 2013, Figure 2). This observation
suggests that UISO may be less sensitive
toward shRNA-induced off-target growth
inhibition compared with MKL-1 and
MKL-2. Consequently, the conflicting
results presented by our two groups
indicate that further control
experiments are essential to remove
the question mark behind the title of
this letter, or establish the opposite. In
this respect, the rescue by reexpression
of the targeted protein is considered as
the ultimate proof for specificity of
shRNA effects (Kittler et al., 2005).
We were not able to achieve this
result for the sT shRNA constructs
used in our study ((Angermeyer et al.,
2013), Figure 2). Thus, it would beAccepted article preview online 12 November 2013; published online 12 December 2013
Abbreviations: LT, large T antigen; MCC, Merkel cell carcinoma; MCV, Merkel cell polyoma virus; shRNA,
small hairpin RNA; sT, small T antigen
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